387
Participants
Start Date
March 8, 2021
Primary Completion Date
September 15, 2022
Study Completion Date
October 7, 2022
BI 456906
BI 456906
Placebo
Placebo
Optimal Clinical Trials, Auckland
The Boden Initiative, Camperdown
Nepean Hospital, Kingswood
UZ Leuven, Leuven
Austin Health, Heidelberg
Eastern Clinical Research Unit, East Ringwood
Royal Adelaide Hospital, Adelaide
P3 Research, Newtown Wellington NZ
Klinische Forschung Berlin GbR, Berlin
Seoul National University Bundang Hospital, Seongnam
Washington Center for Weight Management and Research, Inc., Arlington
PMG Research of Wilmington, LLC, Wilmington
Lucas Research, Inc., Morehead City
TLM Medical Services, LLC, Columbia
Coastal Carolina Research Center, North Charleston
L-MARC Research Center, Louisville
Forskningsenheten Carlanderska, Gothenburg
Salvia Lekston I Madej Sp. J., Katowice
Velocity Clinical Research, Inc., Cleveland
Allegiance Research Specialists, Wauwatosa
Valley Weight Loss Clinic, Fargo
Metabolic Health Center Pawel Bogdanski, Poznan
Diablo Clinical Research, Walnut Creek
Beijing Chao-Yang Hospital, Beijing
Beijing Luhe Hospital Capital Medical University, Beijing
The First Hospital of Jilin University, Changchun
Wuhan Union Hospital, Wuhan
Joanne F Liutkus Medicine Professional Corporation, Cambridge
Bluewater Clinical Research, Sarnia
Canadian Phase Onward Inc., Toronto
LMC Clinical Research Inc. (Bayview), Toronto
Recherche GCP Research, Montreal
Universitätsklinikum Carl Gustav Carus Dresden, Dresden
EB Flevoresearch, Almere Stad
PT & R, Beek
Franciscus Gasthuis, Rotterdam
Albert SchweitzerZiekenhuis, Zwijndrecht
Kyung Hee University Hospital at Gangdong, Seoul
The Catholic University of Korea, Yeouido St.Mary's Hospital, Seoul
Ladulaas Kliniska Studier, Borås
Akademiska sjukhuset, Uppsala
Waterloo Medical Centre, Blackpool
Clifton Medical Centre, Rotherham, Rotherham
Lead Sponsor
Boehringer Ingelheim
INDUSTRY